Does the '2012 IUSTI ECCG report on the diagnosis and management of Neisseria gonorrhoeae infections in Europe' depict the situation in Europe?

M. Unemo*, B. Brooks, M. Cole, J. D.C. Ross, J. A. White, R. Patel

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    4 Citations (Scopus)

    Abstract

    Gonorrhoea is a major public health concern globally. Of particular grave concern is that resistance to the third generation cephalosporins has been identified during recent years. This paper summarises and discusses the results of the '2012 IUSTI European Collaborative Clinical Group (ECCG) report on the diagnosis and management of Neisseria gonorrhoeae infections in Europe'. Although high quality care was reported in many settings, in several other countries the testing, diagnostics, antimicrobial treatment and follow-up of gonorrhoea patients need to be optimized. This, together with increased access to and use of antimicrobial susceptibility testing, is crucial in controlling the emergent spread of cephalosporin-resistant and multidrug-resistant gonorrhoea.

    Original languageEnglish
    Pages (from-to)423-426
    Number of pages4
    JournalInternational Journal of STD and AIDS
    Volume24
    Issue number6
    DOIs
    Publication statusPublished - Jan 2013

    Keywords

    • Europe
    • Gonorrhoea
    • Neisseria gonorrhoeae
    • cefixime
    • ceftriaxone
    • diagnosis
    • sexually transmitted infection
    • treatment

    Fingerprint

    Dive into the research topics of 'Does the '2012 IUSTI ECCG report on the diagnosis and management of Neisseria gonorrhoeae infections in Europe' depict the situation in Europe?'. Together they form a unique fingerprint.

    Cite this